Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis

Transplantation

Volumn 61, Issue 4, 1996, Pages 542-546

  Freeman, Richard B ^a,b   Tran, Son ^a   Lee, Young M ^a   Rohrer, Richard J ^a   Kaplan, Marshall M ^a  

^a TUFTS UNIVERSITY   (United States)

^b Division of Transplant Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OKT 3; VIRUS RNA;

ADULT; ARTICLE; ASCITES; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GRAFT REJECTION; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; VIRUS TITRATION;

FEMALE; GRAFT REJECTION; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MUROMONAB-CD3; RETROSPECTIVE STUDIES; RNA, VIRAL;

EID: 0030006172     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199602270-00005     Document Type: Article

References (14)

1. Feray C, Gigou M, Samuel D, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994; 20: 1137.
2. Wright TL, Donegan E, Hsu HH, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317.
3. Shah G, Demetris AJ, Gavaler JS, et al. Incidence, prevalence and clinical course of hepatitis C following liver transplantation. Gastroenterology 1992; 103: 323.
4. Sheiner PA, Schwartz ME, Mor E, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995; 21: 30.
5. Schoeman MN, Liddle C, Bilous M, et al. Chronic non A-non B hepatitis:lack of correlation between biochemical and morphological activity and effects of immunosuppressive therapy on disease progression. Aust N Z J Med 1990; 20: 56.
6. Fong TL, Valinluck B, Govindarajan S, et al. Effect of short-term prednisone administration on aminotransferase (ALT) levels and HCV-RNA in patients with chronic hepatitis. Hepatology 1993; 18: 87A.
7. McHutchison JG, Wilkes LB, Pokros PJ, et al. Pulse corticosteroid therapy increases viremia (HCV-RNA) in patients with chronic HCV infection. Hepatology 1993; 18: 87A.
8. Stratta RJ, Shaefer MS, Cushing KA, et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg 1989; 124: 1443.
9. Package insert for Quantiplex HCV-RNA assay, version 1.0, Chiron Corporation, Emeryville, California: 1993.
10. Chazouilleres O, Kim M, Ferrell L, et al. Quantitative study of hepatitis C virus in liver transplant recipients. Gastroenterology 1994; 106: 994.
11. Cerny A, Ferrari C, Chisari FV. The class I-restricted cytotoxic T lymphocyte response to predetermined epitopes in the hepatitis B and C viruses. Curr Top Microbiol Immunol 1994; 189: 169.
12. Krawczynski K, Beach M, Bradley DW, Meeks E, Spelbring JE. Immunosuppression and pathogenic studies of acute hepatitis C infection in chimpanzees. Hepatology 1992; 16: 345A.
13. Lake JR, Wright T, Ferrell L, Donegan E, Roberts J, Ascher N. Hepatitis C and B in liver transplantation. Transplant Proc 1993; 25: 2006.
14. Wright TL, Combs C, Kim M, Ferrell L, Bacchetti P, et al. Interferon- α therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994; 20: 773.